Efficacy and safety of camrelizumab plus Lacticaseibacillus paracasei in the treatment of advanced esophageal squamous cell carcinoma: A single-arm, single-center, exploratory trial

DOI: 10.1016/j.cpt.2024.12.003 Publication Date: 2025-01-05T09:03:58Z